Edwards Lifesciences Corporation (EW): Price and Financial Metrics
GET POWR RATINGS... FREE!
EW POWR Grades
- Quality is the dimension where EW ranks best; there it ranks ahead of 92.62% of US stocks.
- The strongest trend for EW is in Stability, which has been heading up over the past 206 days.
- EW ranks lowest in Momentum; there it ranks in the 16th percentile.
EW Stock Summary
- EW has a market capitalization of $54,666,738,169 -- more than approximately 95.61% of US stocks.
- Price to trailing twelve month operating cash flow for EW is currently 47.63, higher than 91.17% of US stocks with positive operating cash flow.
- In terms of volatility of its share price, EW is more volatile than just 4.12% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Edwards Lifesciences Corp, a group of peers worth examining would be EMR, PHG, NEM, ETN, and HUM.
- EW's SEC filings can be seen here. And to visit Edwards Lifesciences Corp's official web site, go to www.edwards.com.
EW Stock Price Chart Interactive Chart >
EW Price/Volume Stats
|Current price||$89.49||52-week high||$98.11|
|Prev. close||$87.94||52-week low||$66.23|
|Day high||$89.94||Avg. volume||2,692,742|
|50-day MA||$86.91||Dividend yield||N/A|
|200-day MA||$84.02||Market Cap||55.63B|
Edwards Lifesciences Corporation (EW) Company Bio
Edwards Lifesciences provides products and technologies to treat structural heart disease and critically ill patients worldwide. It is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The company was founded in 1999 and is based in Irvine, California.
EW Price Forecast Based on DCF Valuation
|Current Price||DCF Fair Value Target:||Forecasted Gain:|
Below please find a table outlining a discounted cash flow forecast for EW, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Edwards Lifesciences Corp ranked in the 20th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Edwards Lifesciences Corp ended up being:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 99. Notably, its equity weight is greater than 90.21% of US equities in the Healthcare sector yielding a positive free cash flow.
- The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately just 8.23% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- EW's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 52.18% of tickers in our DCF set.
|Terminal Growth Rate in Free Cash Flow||Return Relative to Current Share Price|
EW Latest News Stream
|Loading, please wait...|
EW Latest Social Stream
View Full EW Social Stream
Latest EW News From Around the Web
Below are the latest news stories about Edwards Lifesciences Corp that investors may wish to consider to help them evaluate EW as an investment opportunity.
Sands Capital Management ups stakes in tech picks, trims Adobe
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Top Research Reports for JPMorgan, Home Depot & Merck
Leerink Partners Stick to Their Buy Rating for Edwards Lifesciences
Edwards Lifesciences (EW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EW Price Returns
Continue Researching EWHere are a few links from around the web to help you further your research on Edwards Lifesciences Corp's stock as an investment opportunity:
Edwards Lifesciences Corp (EW) Stock Price | Nasdaq
Edwards Lifesciences Corp (EW) Stock Quote, History and News - Yahoo Finance
Edwards Lifesciences Corp (EW) Stock Price and Basic Information | MarketWatch